BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37116276)

  • 1. Preoperative downstaging of pancreatic cancer is associated with improved survival after multi-agent chemotherapy, but not after radiation.
    Nicolais L; Brown AW; Mohamed A; Clark DE; Fitzgerald TL
    Surg Oncol; 2023 Jun; 48():101939. PubMed ID: 37116276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nodal downstaging as a treatment goal for node-positive pancreatic cancer.
    Portuondo JI; Massarweh NN; Zhang Q; Chai CY; Tran Cao HS
    Surgery; 2019 Jun; 165(6):1144-1150. PubMed ID: 30745009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic Cancer with Vascular Involvement: Adherence to Current Standard-of-Care Associated with Improved Survival.
    Mohamed A; Nicolais L; Fitzgerald TL
    Am Surg; 2023 Dec; 89(12):5535-5544. PubMed ID: 36854081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant Radiotherapy is Associated With Improved Pathologic Outcomes and Survival in Resected Stage II-III Pancreatic Adenocarcinoma Treated With Multiagent Neoadjuvant Chemotherapy in the Modern Era.
    Hue JJ; Dorth J; Sugumar K; Hardacre JM; Ammori JB; Rothermel LD; Saltzman J; Mohamed A; Selfridge JE; Bajor D; Winter JM; Ocuin LM
    Am Surg; 2021 Sep; 87(9):1386-1395. PubMed ID: 34382877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic Tumor Regression is Associated With Improved Survival in Pancreatic Cancer.
    Nicolais LM; Caron M; Verdini N; Fitzgerald TL
    Am Surg; 2023 Sep; 89(9):3778-3783. PubMed ID: 37227766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival.
    O'Shea AE; Bohan PMK; Carpenter EL; McCarthy PM; Adams AM; Chick RC; Bader JO; Krell RW; Peoples GE; Clifton GT; Nelson DW; Vreeland TJ
    Ann Surg Oncol; 2022 Sep; 29(9):6015-6028. PubMed ID: 35583691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database analysis.
    Deng A; Wang C; Cohen SJ; Winter JM; Posey J; Yeo C; Basu Mallick A
    Eur J Cancer; 2021 Apr; 147():17-28. PubMed ID: 33607382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of tumor downstaging after neoadjuvant chemotherapy with survival in patients with locally advanced nasopharyngeal carcinoma: a retrospective cohort study.
    Wang W; Peng S; Wu H; Luo Y; Yuan F; Lin Z; Cheng G; Chen S
    J Cancer Res Clin Oncol; 2021 Oct; 147(10):2913-2922. PubMed ID: 34160678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor downstaging after neoadjuvant chemotherapy determines survival after surgery for gastric adenocarcinoma.
    Levenson G; Voron T; Paye F; Balladur P; Debove C; Chafai N; De Dios AG; Lefevre JH; Parc Y
    Surgery; 2021 Dec; 170(6):1711-1717. PubMed ID: 34561115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus.
    Noble F; Nolan L; Bateman AC; Byrne JP; Kelly JJ; Bailey IS; Sharland DM; Rees CN; Iveson TJ; Underwood TJ; Bateman AR
    World J Gastroenterol; 2013 Dec; 19(48):9282-93. PubMed ID: 24409055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Better Defining the Role of Total Neoadjuvant Radiation: Changing Paradigms in Locally Advanced Pancreatic Cancer.
    Vidri RJ; Vogt AO; Macgillivray DC; Bristol IJ; Fitzgerald TL
    Ann Surg Oncol; 2019 Oct; 26(11):3701-3708. PubMed ID: 31286306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment.
    van Roessel S; van Veldhuisen E; Klompmaker S; Janssen QP; Abu Hilal M; Alseidi A; Balduzzi A; Balzano G; Bassi C; Berrevoet F; Bonds M; Busch OR; Butturini G; Del Chiaro M; Conlon KC; Falconi M; Frigerio I; Fusai GK; Gagnière J; Griffin O; Hackert T; Halimi A; Klaiber U; Labori KJ; Malleo G; Marino MV; Mortensen MB; Nikov A; Lesurtel M; Keck T; Kleeff J; Pandé R; Pfeiffer P; Pietrasz D; Roberts KJ; Sa Cunha A; Salvia R; Strobel O; Tarvainen T; Bossuyt PM; van Laarhoven HWM; Wilmink JW; Groot Koerkamp B; Besselink MG;
    JAMA Oncol; 2020 Nov; 6(11):1733-1740. PubMed ID: 32910170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The differential effect of neoadjuvant chemotherapy and chemoradiation on nodal downstaging in pancreatic adenocarcinoma.
    Altimari M; Wells A; Abad J; Chawla A
    Pancreatology; 2023 Nov; 23(7):805-810. PubMed ID: 37599170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of Practice and Improvements in Survival Among Patients With Stage 2/3 Rectal Cancer Treated With Trimodality Therapy.
    Kennecke HF; Bahnson HT; Lin B; O'Rourke C; Kaplan J; Pham H; Suen A; Simianu VV
    JAMA Oncol; 2022 Oct; 8(10):1466-1470. PubMed ID: 35980607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downstaging of T or N predicts long-term survival after preoperative chemotherapy and radical resection for esophageal carcinoma.
    Korst RJ; Kansler AL; Port JL; Lee PC; Kerem Y; Altorki NK
    Ann Thorac Surg; 2006 Aug; 82(2):480-4; discussion 484-5. PubMed ID: 16863749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological Downstaging and Survival Outcomes Associated with Neoadjuvant Chemotherapy for Variant Histology Muscle Invasive Bladder Cancer.
    Chakiryan NH; Jiang DD; Gillis KA; Green E; Hajiran A; Hugar L; Zemp L; Zhang J; Jain R; Chahoud J; Poch M; Manley BJ; Li R; Sexton W; Gilbert SM
    J Urol; 2021 Oct; 206(4):924-932. PubMed ID: 34032503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national cancer database analysis.
    Miccio JA; Talcott WJ; Patel T; Park HS; Cecchini M; Salem RR; Khan SA; Stein S; Kortmansky JS; Lacy J; Narang A; Herman J; Jabbour SK; Hallemeier CL; Johung K; Jethwa KR
    Clin Transl Radiat Oncol; 2021 Mar; 27():15-23. PubMed ID: 33392398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Preoperative Chemotherapy for High Risk Upper Tract Urothelial Carcinoma.
    Foerster B; Abufaraj M; Petros F; Azizi M; Gupta M; Schweitzer D; Margulis V; Iwata T; Kimura S; Shabsigh A; Briganti A; Ku JH; Muilwijk T; Kassouf W; Matin SF; Spiess PE; Pierorazio PM; Hendricksen K; Shariat SF;
    J Urol; 2020 Jun; 203(6):1101-1108. PubMed ID: 31898919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer.
    Wanebo HJ; Glicksman AS; Vezeridis MP; Clark J; Tibbetts L; Koness RJ; Levy A
    Arch Surg; 2000 Jan; 135(1):81-7; discussion 88. PubMed ID: 10636353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.